RNAi antiviral to be developed for hemorrhagic fever

To include Ebola and unspecified others as far as I can tell from the web site for Alnylam, the company that just won almost $40M from DTRA to do the work.
According to the press release, Alnylam will develop a broad spectrum RNAi antiviral therapeutic for hemorrhagic fever over 33 months. They’re already working on [...]

Let’s say it again: it’s NOT smallpox

Here we go again, with reporters using the word “smallpox” over and over in a story about a kid with a vaccinia infection. At least they did manage to slip the correct name into the story.
Tests could prove soldier as smallpox link
LAWTON — A child who came into a Lawton emergency room with a [...]